Covid 19 Vaccine : Serum Institute seeks approval for emergency use of 'kovishield' in the country
The Serum Institute of India has become the primary indigenous company to hunt permission from DCGI for the Corona vaccine.
After Pfizer, the Serum Institute has sought permission from DCGI for the emergency authorization of the corona vaccine. The Corona vaccine from Oxford and AstraZeneca is undergoing trial serum institute of India. The Serum Institute of India has become
The company has submitted data for emergency authorization. Sources said that
SII's application, saying that